Improved detection and characterization of arterial occlusion in acute ischemic stroke using contrast enhanced MRA.


Journal

Journal of neuroradiology = Journal de neuroradiologie
ISSN: 0150-9861
Titre abrégé: J Neuroradiol
Pays: France
ID NLM: 7705086

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 22 02 2019
accepted: 25 02 2019
pubmed: 12 3 2019
medline: 11 2 2021
entrez: 12 3 2019
Statut: ppublish

Résumé

To compare the accuracy and utility of contrast enhanced magnetic resonance angiography (MRA) (CEMRA) to Time of Flight MRA (TOF MRA) during detection and evaluation of occlusions on patients diagnosed with acute ischemic stroke (AIS). This single-center study was approved by our local institutional research ethics board. From August 2014 to July 2016, 131 consecutive adult patients with confirmed AIS were included. Detection of an arterial occlusion and its characterization were evaluated independently with CEMRA or TOF MRA by two blinded neuroradiologists, then by consensus using all available MR sequences. A Cohen's Kappa coefficient (κ) and intra-class correlation coefficients (ICC) were used to compare the two techniques. There was substantial concordance in the detection of arterial occlusion between CEMRA and TOF MRA (κ = 0.75). TOF MRA was more likely to show an arterial occlusion than CEMRA (63 versus 52 patients respectively). There were 13 and 1 false positive arterial occlusion with TOF MRA and CEMRA respectively, and 1 false negative with TOF MRA. There was excellent concordance between the location of arterial occlusions and CEMRA and TOF MRA [κ = 0.89 (0.72-0.97)]. CEMRA was significantly more likely to allow measurement of the thrombus than was TOF MRA [38 (75%) versus 14 (22%)] (P < 0.0001). Our study showed that CEMRA imaging detected arterial occlusions better than TOF MRA in AIS patients and more precisely such that thrombus length and location could be known, which improves the patient's management and care.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
To compare the accuracy and utility of contrast enhanced magnetic resonance angiography (MRA) (CEMRA) to Time of Flight MRA (TOF MRA) during detection and evaluation of occlusions on patients diagnosed with acute ischemic stroke (AIS).
METHODS METHODS
This single-center study was approved by our local institutional research ethics board. From August 2014 to July 2016, 131 consecutive adult patients with confirmed AIS were included. Detection of an arterial occlusion and its characterization were evaluated independently with CEMRA or TOF MRA by two blinded neuroradiologists, then by consensus using all available MR sequences. A Cohen's Kappa coefficient (κ) and intra-class correlation coefficients (ICC) were used to compare the two techniques.
RESULTS RESULTS
There was substantial concordance in the detection of arterial occlusion between CEMRA and TOF MRA (κ = 0.75). TOF MRA was more likely to show an arterial occlusion than CEMRA (63 versus 52 patients respectively). There were 13 and 1 false positive arterial occlusion with TOF MRA and CEMRA respectively, and 1 false negative with TOF MRA. There was excellent concordance between the location of arterial occlusions and CEMRA and TOF MRA [κ = 0.89 (0.72-0.97)]. CEMRA was significantly more likely to allow measurement of the thrombus than was TOF MRA [38 (75%) versus 14 (22%)] (P < 0.0001).
CONCLUSIONS CONCLUSIONS
Our study showed that CEMRA imaging detected arterial occlusions better than TOF MRA in AIS patients and more precisely such that thrombus length and location could be known, which improves the patient's management and care.

Identifiants

pubmed: 30853544
pii: S0150-9861(19)30170-1
doi: 10.1016/j.neurad.2019.02.011
pii:
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

278-283

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

Sarah Dhundass (S)

Department of Neuroradiology, Fondation Ophtalmologique Adolphe de Rothschild, 25, rue Manin, 75019 Paris, France; Department of Neuroradiology,University Hospital of Martinique, Fort-de-France, Martinique, France.

Julien Savatovsky (J)

Department of Neuroradiology, Fondation Ophtalmologique Adolphe de Rothschild, 25, rue Manin, 75019 Paris, France.

Loïc Duron (L)

Department of Neuroradiology, Fondation Ophtalmologique Adolphe de Rothschild, 25, rue Manin, 75019 Paris, France.

R Fahed (R)

Department of Interventional Neuroradiology, Fondation Ophtalmologique Adolphe de Rothschild, 25, rue Manin, 75019 Paris, France.

Simon Escalard (S)

Department of Interventional Neuroradiology, Fondation Ophtalmologique Adolphe de Rothschild, 25, rue Manin, 75019 Paris, France.

Michael Obadia (M)

Department of Neurology, Fondation Ophtalmologique Adolphe de Rothschild, 25, rue Manin, 75019 Paris, France.

Kevin Zuber (K)

Department of Clinical Research, Fondation Ophtalmologique Adolphe de Rothschild, 25, rue Manin, 75019 Paris, France.

Marie Astrid Metten (MA)

Department of Clinical Research, Fondation Ophtalmologique Adolphe de Rothschild, 25, rue Manin, 75019 Paris, France.

Mehdi Mejdoubi (M)

Department of Clinical Research, Fondation Ophtalmologique Adolphe de Rothschild, 25, rue Manin, 75019 Paris, France.

Raphaël Blanc (R)

Department of Interventional Neuroradiology, Fondation Ophtalmologique Adolphe de Rothschild, 25, rue Manin, 75019 Paris, France.

Jean-Claude Sadik (JC)

Department of Neuroradiology, Fondation Ophtalmologique Adolphe de Rothschild, 25, rue Manin, 75019 Paris, France.

Adrien Collin (A)

Department of Neuroradiology, Fondation Ophtalmologique Adolphe de Rothschild, 25, rue Manin, 75019 Paris, France.

Augustin Lecler (A)

Department of Neuroradiology, Fondation Ophtalmologique Adolphe de Rothschild, 25, rue Manin, 75019 Paris, France. Electronic address: alecler@for.paris.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH